Literature DB >> 26305773

Fractal analysis: fractal dimension and lacunarity from MR images for differentiating the grades of glioma.

K A Smitha1, A K Gupta, R S Jayasree.   

Abstract

Glioma, the heterogeneous tumors originating from glial cells, generally exhibit varied grades and are difficult to differentiate using conventional MR imaging techniques. When this differentiation is crucial in the disease prognosis and treatment, even the advanced MR imaging techniques fail to provide a higher discriminative power for the differentiation of malignant tumor from benign ones. A powerful image processing technique applied to the imaging techniques is expected to provide a better differentiation. The present study focuses on the fractal analysis of fluid attenuation inversion recovery MR images, for the differentiation of glioma. For this, we have considered the most important parameters of fractal analysis, fractal dimension and lacunarity. While fractal analysis assesses the malignancy and complexity of a fractal object, lacunarity gives an indication on the empty space and the degree of inhomogeneity in the fractal objects. Box counting method with the preprocessing steps namely binarization, dilation and outlining was used to obtain the fractal dimension and lacunarity in glioma. Statistical analysis such as one-way analysis of variance and receiver operating characteristic (ROC) curve analysis helped to compare the mean and to find discriminative sensitivity of the results. It was found that the lacunarity of low and high grade gliomas vary significantly. ROC curve analysis between low and high grade glioma for fractal dimension and lacunarity yielded 70.3% sensitivity and 66.7% specificity and 70.3% sensitivity and 88.9% specificity, respectively. The study observes that fractal dimension and lacunarity increases with an increase in the grade of glioma and lacunarity is helpful in identifying most malignant grades.

Entities:  

Mesh:

Year:  2015        PMID: 26305773     DOI: 10.1088/0031-9155/60/17/6937

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

1.  Morphological and Fractal Properties of Brain Tumors.

Authors:  Jacksson Sánchez; Miguel Martín-Landrove
Journal:  Front Physiol       Date:  2022-06-27       Impact factor: 4.755

2.  MR imaging based fractal analysis for differentiating primary CNS lymphoma and glioblastoma.

Authors:  Shuai Liu; Xing Fan; Chuanbao Zhang; Zheng Wang; Shaowu Li; Yinyan Wang; Xiaoguang Qiu; Tao Jiang
Journal:  Eur Radiol       Date:  2018-08-30       Impact factor: 5.315

3.  Relationship between necrotic patterns in glioblastoma and patient survival: fractal dimension and lacunarity analyses using magnetic resonance imaging.

Authors:  Shuai Liu; Yinyan Wang; Kaibin Xu; Zheng Wang; Xing Fan; Chuanbao Zhang; Shaowu Li; Xiaoguang Qiu; Tao Jiang
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

4.  Role of the Interplay Between the Internal and External Conditions in Invasive Behavior of Tumors.

Authors:  Youness Azimzade; Abbas Ali Saberi; Muhammad Sahimi
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

5.  Development of a predictive model of growth hormone deficiency and idiopathic short stature in children.

Authors:  Mengdi Cong; Shi Qiu; Rongpin Li; Haiyan Sun; Lining Cong; Zhenzhou Hou
Journal:  Exp Ther Med       Date:  2021-03-17       Impact factor: 2.447

6.  Shape matters: morphological metrics of glioblastoma imaging abnormalities as biomarkers of prognosis.

Authors:  Lee Curtin; Paula Whitmire; Haylye White; Kamila M Bond; Maciej M Mrugala; Leland S Hu; Kristin R Swanson
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

7.  Comparison of Diagnostic Performance of Two-Dimensional and Three-Dimensional Fractal Dimension and Lacunarity Analyses for Predicting the Meningioma Grade.

Authors:  Soopil Kim; Yae Won Park; Sang Hyun Park; Sung Soo Ahn; Jong Hee Chang; Se Hoon Kim; Seung Koo Lee
Journal:  Brain Tumor Res Treat       Date:  2020-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.